<DOC>
	<DOC>NCT02036632</DOC>
	<brief_summary>First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.</brief_summary>
	<brief_title>Eye Patch Therapy for Central Serous Retinopathy (CSR)</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<criteria>Adults 18 years of age and older Both males and females Patients diagnosed with active central serous retinopathy Patients who are willing to use an eye patch in the affected eye for 24 hours Patients who are able to make the follow up appointments as required by the study Individuals under 18 years of age Patients with vision less than 20/40 in the unaffected eye. Patients who are not able to undergo mfERG testing in a realiable manner.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>